Login with your work email address to view charts. No credit card required.
| Art Unit: | 1633 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
435 — Chemistry: molecular biology and microbiology 424 — Drug, bio-affecting and body treating compositions 514 — Drug, bio-affecting and body treating compositions 623 — Prosthesis (i.e., artificial body members), parts thereof, or aids and accessories therefor 506 — Combinatorial chemistry technology: method, library, apparatus 544 — Organic compounds -- part of the class 532-570 series 422 — Chemical apparatus and process disinfecting, deodorizing, preserving, or sterilizing |
| Phone: | (571) 272-2936 |
| Email: | allison.fox@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr (Biolgy) |
| Service: | 22 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 68% over 283 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 64th
|
With Examiner Fox, you have a 68% chance of getting an issued patent by 3 years after the first office action. Examiner Fox is a harder examiner and in the 64th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Fox, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Fox's grant rate is higher than that of Art Unit 1633 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Fox | 1.9 |
| Art Unit 1633 | 2.0 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.